MULTICENTER COMPARISON OF TACROLIMUS (FK-506) WHOLE-BLOOD CONCENTRATIONS AS MEASURED BY THE ABBOTT IM(X) ANALYZER AND ENZYME-IMMUNOASSAY WITH METHYLENE-CHLORIDE EXTRACTION

被引：20

作者：

DAMBROSIO, R

GIRZAITIS, N

JUSKO, WJ

机构：

[1] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,CENT LAB FK506,565 HOCHSTETTER HALL,BUFFALO,NY 14260

[2] FUJISAWA PHARMACEUT CO,CLIN RES DEPT,DEERFIELD,IL

来源：

THERAPEUTIC DRUG MONITORING | 1994年 / 16卷 / 03期

关键词：

TACROLIMUS; FK506; THERAPEUTIC MONITORING; ENZYME IMMUNOASSAY; IM(X) ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY;

D O I：

10.1097/00007691-199406000-00010

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

A multicenter comparison was made between the Abbott IM(X) and enzyme-linked immunosorbent assay (ELISA) procedures for analysis of tacrolimus (FK 506) in whole blood. Proficiency samples and 853 patient specimens obtained after various organ transplantations were assayed by 13 laboratories. Both groups of test samples yielded slightly lower (7 and 13%) values by the IM(X) method, but the difference is not clinically meaningful. The type of organ transplant was not a factor that contributed to assay variation. The Abbott IM(X) results were essentially equivalent to ELISA and considerably facilitates monitoring of FK 506 therapy.

引用

页码：287 / 292

页数：6

共 12 条

[1] VALIDATION AND QUALITY ASSURANCE PROGRAM FOR MONITORING TACROLIMUS (FK-506) CONCENTRATIONS IN PLASMA AND WHOLE-BLOOD [J].